UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Grey Matter Heterotopia and Criminal Responsibility in a Case of Personal Injury Defense

Frontiers in psychiatry, 2020-04, Vol.11, p.261

2020

Volltextzugriff (PDF)

Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects

Frontiers in psychiatry, 2019-01, Vol.9, p.702-702

2019

Volltextzugriff (PDF)

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (51), p.20552-20557

2007

Volltextzugriff (PDF)

Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo

Nature communications, 2024-04, Vol.15 (1), p.3342-3342, Article 3342

2024

Volltextzugriff (PDF)

A generative-discriminative framework that integrates imaging, genetic, and diagnosis into coupled low dimensional space

NeuroImage (Orlando, Fla.), 2021-09, Vol.238, p.118200-118200, Article 118200

2021

Volltextzugriff (PDF)

FXR1P is a GSK3β substrate regulating mood and emotion processing

Proceedings of the National Academy of Sciences - PNAS, 2015-08, Vol.112 (33), p.E4610-E4619

2015

Volltextzugriff (PDF)

Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics

European psychiatry, 2021-04, Vol.64 (1), p.e39-e39, Article e39

2021

Volltextzugriff (PDF)

Physical activity influences adherence to pharmacological treatments in patients with severe mental disorders: results from the multicentric, randomized controlled LIFESTYLE trial

Frontiers in pharmacology, 2023-12, Vol.14, p.1285383-1285383

2023

Volltextzugriff (PDF)

Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia

Brain (London, England : 1878), 2009-02, Vol.132 (2), p.417-425

2009

Volltextzugriff (PDF)

Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain

Schizophrenia (Heidelberg, Germany), 2022-02, Vol.8 (1), p.8-8, Article 8

2022

Volltextzugriff (PDF)

Machine learning-based ability to classify psychosis and early stages of disease through parenting and attachment-related variables is associated with social cognition

BMC Psychology, 2021-03, Vol.9 (1), p.47-47, Article 47

2021

Volltextzugriff (PDF)

DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory

PloS one, 2014-05, Vol.9 (5), p.e95997-e95997

2014

Volltextzugriff (PDF)

Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients

Biomolecules (Basel, Switzerland), 2022-02, Vol.12 (2), p.328

2022

Volltextzugriff (PDF)

Expression of DISC1-interactome members correlates with cognitive phenotypes related to schizophrenia

PloS one, 2014-06, Vol.9 (6), p.e99892-e99892

2014

Volltextzugriff (PDF)

Chitosan nanoparticles: Preparation, size evolution and stability

International journal of pharmaceutics, 2013-10, Vol.455 (1-2), p.219-228

2013

Volltextzugriff (PDF)

Nutraceuticals and their role in tumor angiogenesis

Experimental cell research, 2021-11, Vol.408 (2), p.112859-112859, Article 112859

2021

Volltextzugriff (PDF)

Involvement of vascular endothelial growth factor in schizophrenia

Neuroscience letters, 2021-08, Vol.760, p.136093-136093, Article 136093

2021

Volltextzugriff (PDF)

Auditory mismatch negativity in pre-manifest and manifest Huntington’s disease

Clinical neurophysiology, 2024-06, Vol.162, p.121-128

2024

Volltextzugriff (PDF)

T105. PERSONALITY CHANGES DURING ADOLESCENCE MEDIATE THE RELATIONSHIP BETWEEN GENETIC RISK FOR SCHIZOPHRENIA AND BULLYING VICTIMIZATION IN THE PREDICTION OF ADULT PSYCHOTIC-LIKE EXPERIENCES

European neuropsychopharmacology, 2022-10, Vol.63, p.e225-e226

2022

Volltextzugriff (PDF)

Different Abnormalities of Mismatch Negativity in Schizophrenia and Depression as Assessed with Magnetoencephalography

Journal of psychiatric research, 2024-10

2024

Volltextzugriff (PDF)

A Pattern of Cognitive Deficits Stratified for Genetic and Environmental Risk Reliably Classifies Patients With Schizophrenia From Healthy Control Subjects

Biological psychiatry (1969), 2020-04, Vol.87 (8), p.697-707

2020

Volltextzugriff (PDF)

Reduced magnetic mismatch negativity: a shared deficit in psychosis and related risk

Psychological medicine, 2023-10, Vol.53 (13), p.6037-6045

2023

Volltextzugriff (PDF)

POLYGENIC RISK FOR BODY MASS INDEX AND ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS INTERACT ON SEVERITY OF METABOLIC SYNDROME PHENOTYPES IN PATIENTS WITH SCHIZOPHRENIA

European neuropsychopharmacology, 2022-10, Vol.63, p.e306-e307

2022

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Englisch
(213)
Italienisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Grey Matter Heterotopia and Criminal Responsibility in a Case of Personal Injury Defense

Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivo

A generative-discriminative framework that integrates imaging, genetic, and diagnosis into coupled low dimensional space

FXR1P is a GSK3β substrate regulating mood and emotion processing

Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics

Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study

Physical activity influences adherence to pharmacological treatments in patients with severe mental disorders: results from the multicentric, randomized controlled LIFESTYLE trial

Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia

Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain

BDNF rs6265 methylation and genotype interact on risk for schizophrenia

Machine learning-based ability to classify psychosis and early stages of disease through parenting and attachment-related variables is associated with social cognition

DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory

Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients

Expression of DISC1-interactome members correlates with cognitive phenotypes related to schizophrenia

Chitosan nanoparticles: Preparation, size evolution and stability

Nutraceuticals and their role in tumor angiogenesis

Involvement of vascular endothelial growth factor in schizophrenia

Auditory mismatch negativity in pre-manifest and manifest Huntington’s disease

T105. PERSONALITY CHANGES DURING ADOLESCENCE MEDIATE THE RELATIONSHIP BETWEEN GENETIC RISK FOR SCHIZOPHRENIA AND BULLYING VICTIMIZATION IN THE PREDICTION OF ADULT PSYCHOTIC-LIKE EXPERIENCES

Different Abnormalities of Mismatch Negativity in Schizophrenia and Depression as Assessed with Magnetoencephalography

A Pattern of Cognitive Deficits Stratified for Genetic and Environmental Risk Reliably Classifies Patients With Schizophrenia From Healthy Control Subjects

Reduced magnetic mismatch negativity: a shared deficit in psychosis and related risk

POLYGENIC RISK FOR BODY MASS INDEX AND ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS INTERACT ON SEVERITY OF METABOLIC SYNDROME PHENOTYPES IN PATIENTS WITH SCHIZOPHRENIA

Suchergebnisse filtern